Ardent Health (ARDT) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 20, 2026, to be held virtually for shareholder participation.

• Shareholders are encouraged to review proxy materials and annual report before voting.

Voting matters and shareholder proposals

• Election of eleven directors is up for shareholder vote, with board recommending all nominees.

• Advisory vote on executive compensation (say-on-pay) is included, with board recommending approval.

• Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026, is proposed.

• Proxies may vote on other business that arises during the meeting.

Board of directors and corporate governance

• Eleven director nominees listed for election, including Mark Sotir, Martin J. Bonick, and others.